2022
DOI: 10.3389/fendo.2022.1066208
|View full text |Cite
|
Sign up to set email alerts
|

The use of temozolomide in paediatric metastatic phaeochromocytoma/paraganglioma: A case report and literature review

Abstract: There is increasing evidence to support the use of temozolomide therapy for the treatment of metastatic phaeochromocytoma/paraganglioma (PPGL) in adults, particularly in patients with SDHx mutations. In children however, very little data is available. In this report, we present the case of a 12-year-old female with a SDHB-related metastatic paraganglioma treated with surgery followed by temozolomide therapy. The patient presented with symptoms of palpitations, sweating, flushing and hypertension and was diagno… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 32 publications
0
1
0
Order By: Relevance
“…Temozolomide is used to treat specific types of brain cancer (for example malignant glioma, anaplastic astrocytoma) and has been used for the treatment of metastatic phaeochromocytoma/PGGL in adults and children 135 . It has been proposed as first-line alternative to CVD chemotherapy or as maintenance therapy, especially in patients with mutated SDHB 92 .…”
Section: Malignant Phaeochromocytoma and Paragangliomamentioning
confidence: 99%
“…Temozolomide is used to treat specific types of brain cancer (for example malignant glioma, anaplastic astrocytoma) and has been used for the treatment of metastatic phaeochromocytoma/PGGL in adults and children 135 . It has been proposed as first-line alternative to CVD chemotherapy or as maintenance therapy, especially in patients with mutated SDHB 92 .…”
Section: Malignant Phaeochromocytoma and Paragangliomamentioning
confidence: 99%